Inventiva annonce sa participation à plusieurs conférences investisseurs en octobre 2021
28 sept. 2021 16h00 HE | INVENTIVA
Daix (France), Long Island City (New York, Etats-Unis), le 28 septembre 2021 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de...
Clinical Trial Begins to Evaluate Physiological Effects of a Saturated Fat Found in Milk
23 sept. 2021 09h00 HE | Seraphina Therapeutics, Inc.
SAN DIEGO, Sept. 23, 2021 (GLOBE NEWSWIRE) -- A clinical trial to evaluate the physiological effects of a trace dietary saturated fat found in milk has recently started, led by Dr. Jeffrey Schwimmer...
ZENITH-LOGO-RGB.jpg
Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer (mCRPC) Study
21 sept. 2021 08h00 HE | Zenith Capital Corp.
CALGARY, Alberta, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) and Newsoara BioPharma Co., Ltd. (“Newsoara”) announced today the initiation of a...
Inventiva reports 2021 first half financial results and provides a corporate update
20 sept. 2021 16h10 HE | INVENTIVA
  Cash and cash equivalents at €93.6 m as of June 30, 2021 compared to €105.7 m1 as of December 31, 2020 Initiation of the NATiV3 Phase III clinical study with lanifibranor in NASH R&D...
Inventiva publie ses résultats financiers du 1er semestre 2021 et fait un point sur ses activités
20 sept. 2021 16h10 HE | INVENTIVA
  Trésorerie et équivalents de trésorerie à 93,6 M€ au 30 juin 2021 contre 105,7 M€1 au 31 décembre 2020 Lancement de l’étude clinique de Phase III NATiV3 avec lanifibranor dans la NASH Dépenses...
Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
16 sept. 2021 16h00 HE | INVENTIVA
Seven recruitments with solid track records and complementary profiles to reinforce Inventiva’s clinical expertise, medical team and corporate functions New recruitments further expand the Company’s...
Inventiva annonce des recrutements clés pour accélérer le développement de lanifibranor dans la NASH
16 sept. 2021 16h00 HE | INVENTIVA
Sept recrutements de profils expérimentés et complémentaires pour renforcer l’expertise clinique d’Inventiva, son équipe médicale et ses fonctions corporateCes recrutements permettent à la Société de...
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
16 sept. 2021 08h30 HE | ARCA biopharma, Inc.
First international patient enrolled in BrazilTrial approximately 75% enrolledrNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patientsTopline trial data anticipated in...
MNPR Triangle 2.JPG
Monopar Initiates Open-Label Phase 1b Clinical Trial Evaluating Camsirubicin in Patients with Advanced Soft Tissue Sarcoma
16 sept. 2021 08h00 HE | Monopar Therapeutics Inc.
WILMETTE, Ill., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to...
logo.jpg
ImCheck to Present Early Patient Response Data from the EVICTION Trial at the ESMO Congress 2021
13 sept. 2021 05h00 HE | ImCheck Therapeutics SAS
ImCheck to Present Early Patient Response Data from the EVICTION Trial at the ESMO Congress 2021 Marseille, France, September 13, 2021 – ImCheck Therapeutics today announced that it will present...